American Pain Society's 27th Annual Scientific Meeting (May 8

100

Herpes simplex virus-1 (HSV-1) enkephalin-encoding vector increases enkephalin and decreases inflammatory cytokine expression in cultured PANC-1 pancreatic cells
Hong Yang, MD, PhD, Karin Westlund High, PhD, Bruce Luxon, PhD, Huaizhi Yin and Terry A. McNearney, MD

102

NGF mediated long-lasting changes in central nervous system in neonatal maternal separation induced-visceral hyperalgesia
Eky Chung and Zx Bian

110

Effect of spinal PKGIα inhibition on CFA-induced chronic inflammatory pain
Feng Tao, John Skinner, Yuko Sato and Roger Johns

112

Acute neck trauma in rats produces diffuse and chronic changes in nociceptive responding
S.E. Harte, J. Meyers, D.J. Clauw and T.J. Morrow

114

Anatomical and behavioral correlates of the bilateral chronic constriction injury of neuropathic pain in rats
Sukdeb Datta, MD, Koel Chattejee, PhD, Robert Kline, MS and Ronald G. Wiley, MD, PhD

116

Targeting pain-suppressed behaviors in preclinical assays of chronic pain: Effects of varying acquisition duration on osteoarthritis-induced suppression of wheel running in rats
Hannah Mercer, Jim Cormier, Chloe Adams, Edward J. Bilsky, PhD and Glenn W. Stevenson, PhD

118

CG100649, a novel dual-acting COX-2 and carbonic anhydrase inhibitor: Preclinical pharmacology
Cheol Soon Lee, PhD, Jun Yong Yang, MS, Sun Kyung Kang, MS, Hyun Sil Seo, MS, Cheol Min Kim, PhD, Sun Nam Kim, PhD, Myung Guan Park, PhD, Ho-Jin Chang, PhD, William Schmidt, PhD, Joong Myung Cho, PhD and Seonggu Ro, PhD

120

Physiological relevance of a rodent model of degenerative disc disease
Magali Millecamps, Leigh MacIntyre, Tony Lim and Laura S. Stone, PhD

122

An engineered zinc finger protein repressor of TrkA reduces nociception in a mouse model of bone cancer pain
H. Steve Zhang, PhD, Yann Jouvenot, Andrew McNamara, Shaohua Huang, David Krisky, MD, PhD, Siyuan Tan, Julie Qiao, James Wechuck, S. Kaye Spratt, Darren Wolfe, Joseph Glorioso, Philip Gregory and James Goss

124

Effects of anesthesia on formalin-induced activation in the forebrain: A neuro-imaging study in rats
Pamela E. Paulson, PhD and Thomas Morrow

126

Frequency dependent reduction in cutaneous and muscle hyperalgesia by bi-polar spinal cord stimulation in an animal model of nerve injury
Yumi Maeda, DDS, PhD, Paul Wacnik, PhD and Kathleen Sluka, PT, PhD

128

Catechol O-Methyltransferase (COMT) met/met genotype influences cortisol response and pain symptoms after minor motor vehicle collision (MVC)
Samuel A. McLean, MD, MPH, Luda Diatchenko, MD, PhD, Caroline Reed, Christopher Jones, MD, Erin Zaleski, MA, Yogesh Mistry, MD, Robert Swor, MD, Mark Sochor, MD, Israel Liberzon, MD, PhD, Daniel J. Clauw, MD and William Maixner, DDS, PhD

130

Differential responses of pronociceptive neurons in the rostral ventromedial medulla during acute capsaicin-evoked visceral and somatic hyperalgesia
Raul Sanoja, Victor Tortorici, Carlos Fernandez and Fernando Cervero

132

Diffuse noxious inhibitory control function in women with provoked vestibulodynia
Katherine Stella Sutton, MA, Caroline Pukall, PhD and Susan Chamberlain, MD

136

A comparison of two wind-up methodologies in patients with osteoarthritis vs normal controls
Gila I. Wallach, MS, Christine Gagnon, PhD and R. Norman Harden, MD

138

Effect of lower leg eccentric actions on the nociceptive flexion (R-III) reflex, foot tremor, and delayed onset muscle pain
Jeffrey D. Pasley, PhD and Patrick J. O'Connor, PhD

140

Voxel based morphometry analysis of patients with chronic neuropathic pain
Meredith J. Barad, MD, Takefumi Ueno, MD, PhD, Fumiko Hoeft, MD, PhD, Robert Moulton, BS, Jarred Younger, PhD, Gary Glover, PhD and Sean Mackey, MD, PhD

144

Mechanisms underlying modulation of repeated thermal stimulation
Christopher King, PhD, Alison Riley, Fong Wong, Andre Mauderli and Joseph Riley

146

Evaluation of sympathetic cholinergic response in spinal cord injury: Is a subset of SCI pain sympathetically maintained?
R. Norman Harden, MD, Arzhang Zereshki, MD, Joseph Graciosa, BA, Ritu Sarin, MS and Geke Van der Ende, MS

148

Antinociceptive effects of lumbar intrathecal neuropeptide y-saporin
Robert Kline, MS, Laurie Lemons and Ronald Wiley

150

Supraspinal modulation of trigeminal nociception and pain: Emotional controls (ECON) and diffuse noxious inhibitory controls (DNIC)
Jamie L. Rhudy, PhD and Amy E. Williams, MA

152

Biopsychosocial influence on induced shoulder pain
Steven Z. George, PhD, Geoffrey Dover, PhD, Margaret R. Wallace, PhD, Brandon K. Sack, BS, Deborah M. Herbstman, BA, Ece Aydog, Jessica Neff, Michael Fleming and Roger B. Fillingim, PhD

154

Pain experiences during a 26.2 mile marathon run
Patrick J. O'Connor and Jessica Dyke

158

Efficacy of milnacipran in the treatment of fibromyalgia syndrome: A 3-month, double-blind, placebo-controlled trial
Daniel J. Clauw, MD, Robert H. Palmer, MD, Kim Thacker, MD, R. Michael Gendreau, MD, PhD, Judy F. Gendreau, MD and Philip Mease, MD

160

Hypersensitivity to cutaneous thermal nociceptive stimuli in myofascial pain and fibromyalgia syndromes
Fong Wong, DDS, MS, Tom Currie, Christopher King and Andre Mauderli

162

Pain modulation in IBS and MPS patients: Deficiency of Diffuse Noxious Inhibitory Controls
Christopher King, PhD, Thomas Currie, BS, Fong Wong, DDS, MS, Andre P. Mauderli, DDS, PhD and Joseph L. Riley, PhD

164

Symptom reporting in people with Fibromyalgia
James P. Robinson, MD, PhD, Hilary D. Wilson, PhD, Kimberly S. Swanson, PhD and Dennis C. Turk, PhD

166

Effectiveness of psychological therapies in the rehabilitation of individuals with Fibromyalgia: Responder analysis
Dennis C. Turk, PhD, James P. Robinson, MD, PhD, Kimberly S. Swanson, PhD and Hilary D. Wilson, PhD

168

Milnacipran has low potential for drug-drug interaction
Antonia Periclou, PhD, Stephen M. Coutts, PhD, Srinivas G. Rao, MD, PhD and Robert H. Palmer, MD

170

Milnacipran is safe and well tolerated in the treatment of fibromyalgia syndrome
Judy F. Gendreau, MD, Robert H. Palmer, MD and Kim Thacker, MD

174

Atypical limb pain from a carpal tunnel ganglion cyst
Nathan J. Rudin, MD, MA and Stefan Zachary, DO, MS

176

Parent's perspective of managing pain at home following tonsillectomy
Kimberly A. Sutters, RN, PhD, Marilyn C. Savedra, RN, DNS, FAAN, Christine Miaskowski, RN, PhD, FAAN, Steven Paul, PhD, Danielle Holdridge-Zeuner, RN, Steven Waite and Brent Lanier, MD

178

Diffuse Noxious Inhibitory Controls Observed Across the Lifespan
Ashley Pare, BS, Michael Donovan, Aylin Okcular, Jamie Saltz, Lindsay Place, Kati Rouisse, Christina Tseng, Jamie Zipnik, Joseph Riley, Christopher King and Andre Mauderli

182

Baseline Pain And Analgesic Consumption Over Time As A Determinant of Post Op Pain Severity
Daniel Solorio, Douglas Baum and Michael Kuss

184

Is the improvement in vitality independent of the improvements in sleep interference and pain in patients with diabetic peripheral neuropathic pain? Responses to treatment with duloxetine
David A. Fishbain, MD, FAPA, Jerry Hall, Richard Risser and Jill Gonzales

186

Safety and Tolerability of Duloxetine in the Treatment of Patients with Fibromyalgia: Analysis of 5 Studies
Ernest Choy, MD, Philip Mease, MD, Daniel Kajdasz, PhD, Madeline Wohlreich, MD, Daniel Walker, PhD and Amy Chappell, MD

188

Total freedom from cancer pain at a tertiary cancer centre in India –A retrospective analysis of 3238 patients.
Sushma Bhatnagar, MD

190

The safety of BEMA^TM(BioErodible MucoAdhesive) Fentanyl use for breakthrough (BTP) pain in cancer patients
Neal E. Slatkin, WD Charlie Hill and Andrew Finn

192

Lack of adverse events affecting the mouth in three clinical trials of BEMA^TM (BioErodible MucoAdhesive) Fentanyl
David Blum and Andrew Finn

196

A longitudinal examination of cancer pain: The role of gender and breakthrough pain
Julia Caldwell, MD, Tamera Hart-Johnson, MS and Carmen R. Green, MD

198

Therapeutic outcomes of the integrative care package for back pain with disc herniation
Youngkwon Choi, medical, doctor, Yousuk Youn, SeungRo Kwon and Sangho Lee

200

Incidence of spinal surgery for back pain patients
Adnan Zubovic and Frank Dowling

202

Atypical Presentation of Occipital Neuralgia
Matthew P. West, MD, BS and Hong Wu, MD, MS

204

Long-term efficacy of Lacosamide in subjects with painful distal diabetic neuropathy
Tibor Hidvégi, MD, Michael Bretschneider, Stephan Thierfelder, Ken Sommerville and Sabine Bongardt

206

Tolerability of Once-Daily Cyclobenzaprine Hydrochloride Modified-Release 15 mg and 30 mg for Low Back and Neck Pain Associated with Muscle Spasm
Arnold Weil, MD, MBA, Steven C.-K. Chang, PhD, Charles Altman, MD, MBA and Donald R. Taylor, MD

208

Pain quality predicts response to sodium channel blockade with lidocaine
Uta Maeda, Ian Carroll, Allyson Mackey, Jarred Younger and Sean Mackey

210

Results from a phase I, double-blind, randomized, placebo-controlled, multiple-dose study evaluating the safety, tolerability, and pharmacokinetics of oral doses of NKTR-118
David Sahner, MD, Huub van Paaschen, MD, Annette Marcantonio, MBA and Michael A. Eldon, PhD

214

Symptoms of opioid withdrawal after discontinuation of tapentadol immediate release, an analgesic with mu-opioid receptor agonism
David Upmalis, Akiko Okamoto, Charles Oh, Manuela Buzoianu, Jens-Ulrich Stegmann and Martin Hale

216

Efficacy of IV ketamine to treat pain disrorders in the pain clinic
John Claude Krusz, PhD, MD, Jane Cagle, LVN and Stephanie Hall, BS MPH

218

Efficacy of IV ketamine in treating Refractory Migraines in the Clinic
John Claude Krusz, PhD, MD, Jane Cagle, LVN and Stephanie K. Hall, BS, MPH

220

Calcitonin nasal spray effective in limb pain following idiopathic brachial plexitis
Nathan J. Rudin, MD, MA

222

Analgesic efficacy of tapentadol immediate release in patients with pain from end stage joint disease
Craig Hartrick, Akiko Okamoto, Charles Oh, Ilsa Van Hove, Jens-Ulrich Stegmann and David Upmalis

224

Tapentadol immediate release compared with oxycodone immediate release for the relief of moderate-to-severe pain in patients with end stage joint disease
Marc Afilalo, Charles Oh, Akiko Okamoto, Ilse Van Hove, Jens-Ulrich Stegmann and David Upmalis

226

Tapentadol immediate release is associated with improved gastrointestinal tolerability compared with oxycodone immediate release over 90 days in patients with lower back or osteoarthritis pain
Charles Oh, David Upmalis, Akiko Okamoto, Manuela Buzoianu, Jens-Ulrich Stegmann and Joseph Gimbel

228

Repetitive paravertebral nerve block using a mixture of ketamine, bupivacaine and methylprednisolone for pain relief in intractable post herpetic neuralgia
Mohammad Maroof, MD, Hammad Usmani, Ahmed Obaid, Ahmed Muneeb, Rashid Khan and Farah Nasreen

230

Pharmacokinetics of a novel liquid-gel formulation of diclofenac potassium
Keith Moore, PharmD, Stephen Boesing, MS and James Young, PhD

232

CG100649, a Novel Dual-Acting COX-2 and Carbonic Anhydrase Inhibitor: Ascending Single Dose and Multi-Dose Pharmacokinetics and Safety Evaluation in Healthy Male Subjects
Seonggu Ro, PhD, Young-Ho Park, Tim Mant, FRCP, FFPM, William K. Schmidt, Min Suh Kang and Joong Myung Cho

234

CG100649, a Novel Dual-Acting COX-2 and Carbonic Anhydrase Inhibitor: Multi-Dose Pharmacokinetics and Safety Evaluation in Healthy Male and Female Subjects
William K. Schmidt, PhD, Bernard Chung, Kei-Lai Fong, PhD, Suzanne Swan, MD, Courtney Cannon, PA-C, Harry Alcorn, PharmD, Hongkun Liang, PhD, Yongdong Zhu, Min Suh Kang, Cheol Soon Lee, Cheol Min Kim, Sun Nam Kim, Jun Yong Yang, Myung Guan Park, Ho-Jin Chang, Seonggu Ro and Joong Myung Cho

236

Relative bioavailability of plasma naltrexone from crushed ALO-01 (an investigational, abuse-deterrent, extended-release, morphine sulfate formulation with sequestered naltrexone) to a naltrexone oral solution
Franklin Johnson, MS, James B. Jones, MD, PharmD and Joseph Stauffer, DO

238

Sex Differences in Side Effects to Butorphanol and Morphine
Toni L. Glover, MA, RN, Margarete Ribeiro-Dasilva, Teonia Burton, Wesley Gladin, Danielle Case, Roland Staud, MD and Roger B. Fillingim, PhD

240

A pharmacokinetic profile of intranasal hydromorphone in emergency room trauma patients
Peter G. Lacouture, PhD, Anita Rudy, PhD, Franz Hefti, PhD, Thomas Clinch, PhD and Daniel P. Wermeling, PharmD

242

Marked and sustained reduction of opioid requirements after administration of intravenous naloxone for respiratory depression
Shail Maingi, MD, Natalie Moryl, MD and Charles Inturrisi, PhD

244

Symptomatic hypoglycemia due to escalating doses of intravenous methadone
Shail Maingi, MD, Moryl Natalie, MD and Faskowitz Andrew, MD

246

Actigraphy-Based Evaluation of Sleep Improvement during Treatment of Chronic Neuropathic Pain with Transdermal Fentanyl
Danesh Mazloomdoost, MD, Brenda Jamerson, PharmD and Srinivasa Raja, MD

248

Analgesic efficacy and safety of controlled-release hydrocodone and acetaminophen tablets, dosed twice daily, for moderate to severe mechanical chronic low-back pain: A randomized, double-blind, placebo-controlled withdrawal trial
Christine Codding, Dale Levinsky, Martin Hale, James W. Thomas, Earle Lockhart and Rita Jain

250

Oxymorphone extended release in Hydrocodone-experienced patients with chronic low back pain: Subgroup analysis of a 12-week, randomized, double-blind, placebo-controlled study
Martin E. Hale, MD, Tina Ma, PhD, Harry Ahdieh and Rosemary Kerwin

252

Risk factors for delayed opioid cessation following surgery
Ian Carroll, MD, MS, Charlie Wang, Jen Wang, Matthew Gillespie, Peter Barelka, Keith Humphreys, PhD, Jodie Trafton, PhD, Frederick Dirbas, MD, Stuart Goodman, MD, Richard Whyte, MD, Walter Cannon, MD, George Yang, MD, John Pollard, MD and Sean Mackey, MD, PhD

254

Impact of fentanyl buccal tablet on both patient and clinician ratings of patient function
John T. Farrar, MD, PhD, Edward Michna, MD, John Messina, PharmD and Fang Xie, PhD

256

Subject's and physician's global assessment of chronic low-back pain status after treatment with 12-hour extended-release hydrocodone/acetaminophen tablets: A 3-week open-label, 12-week randomized double-blinded placebo-controlled withdrawal trial
Christine Codding, Dale Levinsky, Martin Hale, James W. Thomas, Pamela Vo, Steven E. Marx, Earle Lockhart and Rita Jain

258

Trends in use of opioids by chronic non-cancer pain type and number, among Arkansas Medicaid and Wellpoint enrollees: results from the TROUP study
Jennifer Braden, MD, MPH, Mark Sullivan, MD, PhD, Ming-Yu Fan, PhD, Mark Edlund, MD, PhD, Bradley Martin and Andrea DeVries, PhD

260

Efficacy and safety evaluation of an extended-release morphine sulfate formulation with sequestered naltrexone for the treatment of osteoarthritis
Nathaniel P. Katz, MD, MS, Stephen Sun, MD, Linda Fox, Franklin Johnson, MS, George Wagner, BS and Joseph Stauffer, DO

262

Acute pain management research in the emergency department - considerations for model development
Peter G. Lacouture, PhD, David Dreitlein, MD, Selim Suner, MD, Franz Hefti, PhD, Thomas Clinch, PhD, Deborah E. Pike, BS and Daniel P. Wermeling, PharmD

264

Aerosolized Liposome-Encapsulated Fentanyl (AeroLEF™) via pulmonary administration allows patients with moderate to severe post-surgical acute pain to self-titrate to effective analgesia
Alexander J. Clark, MD, FRCPC, Maggie Rossiter-Rooney, RN and Filomena Valle-Leutri, BS

266

A retrospective study of the effects of a pain management protocol for pediatric posterior spinal fusion
Sharon K. Wrona, RN, MS, PNP

268

A Randomized Double-Blinded Study of Clonidine as an Analgesic Adjuvant to Continuous Extrapleural Intercostal Bupivacaine for Post-Thoracotomy Pain
Sushma Bhatnagar Sushma Bhtnagar, MD

270

Evaluation of morphine sparing effects of gabapentin for relief of postoperative pain in patients undergoing lumbar laminectomy: A double blind study
Gagandeep Goyal, MD, S. Gombar, MD, J. Horrow, MD and K.K. Gombar, MD

272

New Neurological Insult with an Indwelling Epidural: A Case Report
Julia Caldwell, MD and Naeem Haider, MD

274

Competency, compassion and contentment: Nurses' attitudes toward pain associated with peripheral venous access in pediatric patients
AnnMarie Papa, MSN, RN, CEN, Rhonda Morgan, RN, MSN, CEN and William T. Zempsky, MD

276

Transdermal cannabidiol has therapeutic potential for amelioration of experimental arthritis and secondary thermal hyperalgesia
Karin Westlund High, PhD, Liping Zhang, PhD, Fei Ma, PhD, Sarah Abshire, Dana Hammell and Audra Stinchcomb, PhD

278

Efficacy and tolerability of FLECTOR^® Patch (diclofenac epolamine topical patch) in the treatment of minor soft tissue injury pain
William Carr, MD, MBChB, CFP, Pieter Beks, MD, Clarence Jones, PhD, Stefano Rovati, MSc, Merrell Magelli, PharmD and Stephen Sun, MD

280

CNS injury following intra-arterial steroid injection: More than microembolization?
Joshua D. Dawley, Tobias Moeller-Bertram, Mark Wallace and Piyush Patel

282

Effect of propranolol on TMD patients: preliminary findings
Inna E. Tchivileva, MD, Pei Feng Lim and William Maixner

284

Effect of pregabalin on dynamic allodynia in patients with postherpetic neuralgia (PHN): Results from a double-blind, randomized, controlled trial (RCT)
Jeannette A. Barrett, Rainer Freynhagen, Ed Whalen, Kem Phillips and Edith Durso-DeCruz

286

Efficacy of duloxetine in patients with fibromyalgia: Pooled analysis of four placebo-controlled clinical trials
Lesley M. Arnold, MD, Daniel Clauw, Madelaine Wohlreich, MD, Fujun Wang, Jonna Ahl, Paula J. Gaynor and Amy Chappell, MD

288

An Unusual Case of Low Back Pain
Gustavo A. j. Blanco, Osvaldo Bruera, Anselmo Rodriguez Loffredo, Alejandro Paulo, Eduardo Dulbecco, Alberto Dubrovsky and Facundo Manes

290

Pain Changes in Pregabalin-Treated (Lyrica®) Fibromyalgia Patients Associate with Anxiety and Depression Changes
Lesley M. Arnold, MD, L. Pauer, E. Whalen, J. Barrett, PhD and T. Leon

292

Treatment Effects on Changes in Pain and Changes in Sleep: Pregabalin (Lyrica®) in Fibromyalgia (FM) Patients
I. Jon Russell, PhD, MD, L. Pauer, E. Whalen and J. Barrett, PhD

294

Treatment for Pain Management and Addiction
Jerry N. Rand, MD, APMC, ASAM and David Bergman, ASAM, APS, PA

296

Impact of pregabalin on the cost of pharmacotherapy for fibromyalgia from a US perspective
Montserrat Vera-Llonch, MD, MPH, Alesia Sadosky, PhD, Ellen Dukes and Gerry Oster, PhD

298

Differences in central neural pain processing following acupuncture and sham acupuncture therapy in fibromyalgia (FM)
Ann A. Poznanski, PhD, Michael Hsu, MD, Richard Gracely, PhD, Daniel Clauw, MD and Richard Harris, PhD

300

Cortisol levels before and after isometric contractions are not influenced by the menstrual cycle
Marie Hoeger Bement, Manda Keller, April Harkins and Sandra Hunter

302

Opioids for chronic pain: To wean or not to wean
Michael E. Robinson, PhD, Virgil Wittmer, PhD, Steven Z. George, PhD, Jason Beneciuk and Roger B. Fillingim, PhD

304

Changes in catastrophizing predict pain ratings in persons with limb loss
Susan E. Hofkamp, PhD, Stephen Wegener, PhD, Ellen J. MacKenzie, PhD, Patti Ephraim, MPH, Dawn M. Ehde, PhD, Rhonda M. Williams, PhD and Brendan Klick, MS

306

The effect of evidence-based education modifications on fear-avoidance beliefs and pain catastrophizing for patients with low back pain
Steven Z. George, PhD, Carolina Valencia and Michael E. Robinson, PhD

308

Personality correlates of pain and nociceptive sensitivity: The Control subscale of the constraint trait
Mary C. Chandler, Emily J. Bartley, Carl Lattimore, Jennifer L. Russell, BA, Amy E. Williams, MA, Klanci M. McCabe and Jamie L. Rhudy

310

Cognitive behavioral components of mindfulness in patients with chronic pain
Lance M. McCracken, PhD, Miles Thompson, DclinPsy and Kevin E. Vowles, PhD

312

Anxiety sensitivity, experiential avoidance, and chronic pain
Lance M. McCracken, PhD, Edmund M. Keogh, PhD and Kevin E. Vowles, PhD

314

Is there a role for biofeedback in the managment of acute postopoerative pain?
Seetal Cheema, MD, Allen H. Lebovits, PhD and Michel Y. Dubois, MD

316

Psychological and physiological correlates of a brief intervention to enhance self-regulation in chronic pain
John E. Schmidt, PhD, W. Michael Hooten, MD, Jennifer L. Kerkvliet, MA, Kevin Reid, DMD and Michael Joyner, MD

318

Using electronic diaries to monitor intervention compliance in chronic pain
John E. Schmidt, PhD, Mary Farmer, Jennifer L. Kerkvliet, MA and W. Michael Hooten, MD

320

In-vivo vs. standard catastrophizing in multiple pain measures among healthy, TMD and arthritis patients
Claudia M. Campbell, PhD, Tarek R. Kronfli, BA, Luis F. Buenaver, PhD, Jennifer Haythornthwaite, PhD, Michael T. Smith, PhD and Robert Edwards, PhD

322

Contributions of psychological flexibility and traditional pain management strategies on outcomes following interdisciplinary treatment for chronic pain
Kevin E. Vowles, PhD and Lance M. McCracken, PhD

324

Acceptance: A psychological resource in adaptation to chronic pain
Nomita Sonty, PhD, Nanshi Sha, MSc, Erik Sowder, PhD, Mark Green, MD and Leena Mathew, MD

326

A randomized study of the effects of catastrophizing on experimental pain
Joel E. Bialosky, MS, PT, Adam T. Hirsh, MS, Michael E. Robinson, PhD, Ryland Galmish and Steven Z. George, PhD

328

Pain catastrophizing assessed before and after experimental pain testing: Temporal stability and relations with pain and nociception
Jennifer L. Russell, MA, Emily J. Bartley, Klanci M. McCabe, Amy E. Williams and Jamie L. Rhudy

330

Do food fantasies facilitate coping with acute pain?
Hamid Hekmat, PhD, Peter Staats, MD and Arthur Staats, PhD

332

Hypnosis for treatment of HIV neuropathic pain
David Dorfman, PhD, Guy Montgomery, Mary-Catherine George, George Davidson, Katherine Barboza, Lynne Bartell and David M. Simpson

334

Long-term outcomes in chronic pain patients: The relationship between perceived disability, cognitive and affective factors, and adjustment
Nancy Beckman, Ellyn Turer, Traci Scherdell, Moira Dux and Kenneth Lofland

336

Depressive history and catastrophizing in chronic pain patients and their spouses
Jody A. Coppersmith

338

Pain and motivation to smoke tobacco: Experimental findings and a theoretical conceptualization
Joseph W. Ditre, MA and Thomas H. Brandon, PhD

340

Prospective analysis of the relationship between pain responses and symptom reports
Erin Alice Dannecker, PhD, ATC and Jason G. Craggs, PhD

342

Effects of sleep on the immunologic response to negative cognition in persons with chronic pain
Gail K. Larsen, BS, Beth Darnall, PhD and Heather Zwickey, PhD

346

Investigating pain assessment and treatment disparities: A novel virtual human technology application
Adam T. Hirsh, Steven Z. George, Roger B. Fillingim, PhD, William M. Perlstein, PhD, Shankar N. Manamalkav and Michael E. Robinson

348

Confirmatory factor analysis of the Pain Catastrophizing Scale in African Americans with pain in a primary care setting
April Hazard Vallerand, PhD, RN, FAAN, Barbara Pieper, PhD, RN, FAAN, Ellen DiNardo, MSN, RN and Cheryl Nordstrom, PhD

350

Incorporating the facial pain patient's perspective into treatment: Comparisons across three pain groups
Lauren A. Stutts, MS, Evangelia Banou, PhD, R. Corey McCulloch, MS, Jason G. Craggs, PhD, Lori B. Waxenberg, PhD, Henry A. Gremillion, MD and Michael E. Robinson, PhD

352

Comprehensive Pain Program Initial Evaluation in Hawaii: Preliminary Study
Ira D. Zunin, Steve Orenstein, Mahana Chang and Sungkun Cho

354

Development of a pain assessment scale for patients with moderate to severe brain injury: A pilot study
Rebecca Carroll, MD, Allison M. MacDonald, Nicholas H. Weber, BS, Christine M. Gagnon, PhD, Kelly M. Leinberger, BS and R. Norman Harden, MD

356

Effects of physician specialty on assessment of pain and disability
Raymond Tait, PhD, Laura Miller, BS, Katie Scolari, BS and John Chibnall, PhD

358

Identifying the psychosocial influences on walking quality
Jane E. Clarke, BSc, (hons), MSc, Christopher Eccleston, PhD and Kevin E. Vowles, PhD

360

Comparing the differential item functioning of the Short-Form McGill Pain Questionnaire between Hispanic and non-Hispanic pain patients
Jennifer L. Zinke, PhD, Chow S. Lam, PhD, Louis Fogg, PhD, R. Norman Harden, MD and Kenneth Lofland, PhD

362

Comparison of interview based and EuroQoL derived utilities among patients with chronic pain
Seema Kini, Laura DeLong, Mary Jayne McIlwain, Michael Schaufele, MD, Shinko Lin, Livia Van, Tunisia Finch, Ricardo Berrios, Alice Huang, Anne Marie McKenzie-Brown, MD and Suephy Chen, MD, MS

364

Pain Outcomes Evaluation Tool (POET): Preliminary patient profile data electronically acquired at an academic tertiary care pain center
Gilbert J. Fanciullo, MD, MS, Julie Sorenson, MD, MPH, Tabitha Washington, MD, MS, Ralph Beasley, MD, Devi Nampiaparampil, MD and Stephanie L. Singleton

366

The Pain Descriptor System: A Cumulative Refinment of the Vocabulary for Pain Assessment
Ephrem Fernandez, PHD

368

1. Fibromyalgia patients have high expectations of symptom relief during rheumatology office visits
Roland Staud, MD, Erin O'Brien, Jason Craggs, Shana Peak, Eubee Koo, Donald Price and Michael Robinson

370

Outcomes in obese and non-obese patients with chronic osteoarthritis (OA) pain treated with tramadol HCl extended-release (tramadol ER)
Jennifer Hanlon, Carmela Benson, Kavita Gajria, Daniel Ng, Peggy Lin, Jeff R. Schein, Mark Kosinski and John Freedman

372

Comparing response rates in patients with chronic osteoarthritis (OA) pain of the knee or hip receiving tramadol extended-release (TER)
Kavita Gajria, Carmela Benson, Samir Mody, Jennifer Hanlon, Peggy Lin, Jeffrey Schein and John D. Freedman

374

Health-related quality of life (HRQoL) among patients experiencing acute and chronic pain: Results from a survey of 606 pain patients in the United States
Pamela Vo, Steven Marx and Leslie Penles

376

Health status measurements vs. utilities in quality of life assessment of chronic pain
Livia Van, Laura DeLong, MD, MPH, Michael Schaufele, MD, Seema Kini, Mary Jayne McIlwain, Shinko Lin, Tunisia Finch, Ricardo Berrios, Alice Huang, Anne Marie McKenzie-Brown, MD and Suephy Chen, MD, MS

378

Suicidal ideation, plans and attempts among individuals with chronic pain conditions: data from the National Co-morbidity Survey Replication
Jennifer Braden, MD, MPH and Mark Sullivan, MD, PhD

380

Characteristics of women at risk for persistent abdominal/pelvic pain
Frank F. Tu, MD, MPH, Sangeeta Senapati, MD, MS, Brittany Bettendorf and Sophie Shay

382

The influence of negative mood and pain catastrophizing on outcomes from a chronic pain rehabilitation program
Steven Z. George, PhD, Virgil Wittmer, PhD, Jason Beneciuk, Roger B. Fillingim, PhD and Michael E. Robinson, PhD

384

Virtual human technology as a novel approach to investigating pain-related clinical decision making
Adam T. Hirsh, Shankar N. Manamalkav and Michael E. Robinson

386

Assessing willingness to try pharmacological versus nonpharmacological treatments for pain in patients with temporomandibular disorders
Susan E. Hofkamp, PhD, Luis F. Buenaver, PhD, Michael T. Smith, PhD, Robert Edwards, PhD, Eleni Sarlani, DSS, Edward, G. Grace, DDS and Jennifer Haythornthwaite, PhD

388

What Patient Variables Are Associated With An Expressed Wish to Kill A Doctor
David A. Fishbain, MD, FAPA, Daniel Bruns, PsyD, John Mark Disorbio, EdD and John E. Lewis, PhD

390

Pain measurement: Long term stability of VAS pain intensity ratings assessed by means of a pain scale calibration exercise
Ronald S. Leight, PhD, James P. Bowman, MS and Ashley Barlow, DPhMed

392

Patient and physician sociodemographic factors impact treatment recomendations
Leena Mathew, MD, Nomita Sonty, PhD and Nanshi Sha, MSc

394

Does parent pain history moderate the agreement between child and parent pain ratings?
Anne M. Lynch, PhD, Keeley Harding, Debbie Wolf, Irina Parkins, Susmita Kashikar-Zuck, PhD, Lori McKenna, Alexandra Szabova and Kenneth Goldschneider

396

Screening pain and fatigue conditions using the Complex Medical Symptoms Inventory
Michael Geisser, PhD, Daniel Clauw, Richard Gracely, Kirsten Ambrose, Angela Lyden and David Williams

400

Large iliopsoas cyst causing femoral nerve palsy and lower extremity radicular pain mimicking spinal pathology
Jagan Devarajan and Lokesh Ningegowda

402

Conceptual model of societal burden of non-medical use of prescription opioids/analgesics among patients with chronic pain
Jing Ju, PharmD, C. Daniel Mullins, PhD, Mary Lynn McPherson, PharmD, BCPS and Anthony Tommasello, PhD, MS

404

Texas pharmacists' knowledge, attitudes, and practices may contribute to inadequate pain care
Scott A. Strassels, PharmD, PhD, Jodie L. Pepin, PharmD, Helen Ross Petty, Karen Torges and Larry Driver, MD

406

Pain and analgesia knowledge, attitudes and practices among Texas nurses
Scott A. Strassels, PharmD, PhD, Helen Ross Petty, Karen Torges and Larry Driver, MD

410

Geographic differences and validation of prescription opioid abuse rates: A multi-data stream analysis
Stephen F. Butler, PhD, John S. Brownstein, Andrea Licari and Simon Budman

412

Women who abuse prescription opioids: findings from the National Addictions Vigilance Intervention and Prevention Program
Stephen F. Butler, PhD, Traci C. Green, Andrea Licari and Simon Budman

414

Enhancement of a Scale to Measure Attractiveness of Prescription Opioid Formulations
Stephen F. Butler, PhD, Kathrine Fernandez, MPH, Alan Chang, Christine Benoit and Nathaniel P. Katz, MD, MS

American Pain Society's 27th Annual Scientific Meeting (May 8 – 10, 2008): Poster Session II

P2 Poster Session II